A groundbreaking ceremony for the facility, which will include expansive cleanroom facilities, was held in June
MicroVention, a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, has announced that it will build its new 205,000 square-foot worldwide headquarters at the Summit Office Campus in Aliso Viejo (California, USA).
MicroVention is one of the leaders in its field, focused on the development of catheter-based minimally invasive neuro-endovascular devices and technologies to treat cerebral aneurysms and other neurovascular diseases.
This new facility will consolidate MicroVention’s operations into one building and is expected to support the growth and expansion of products offered under the MicroVention and Terumo brands for the foreseeable future. The new building will house the company's research and development centre and manufacturing, which includes expansive cleanroom facilities. It will also house corporate finance and administrative functions, global marketing and sales activities.
‘We are very excited about the initiation and development of this new ‘Innovation Center’ for MicroVention and to be commemorating the start of its construction with a special groundbreaking ceremony,’ said Richard Cappetta, President and Chief Executive officer of MicroVention.
MicroVention sets the standard for excellence in its industry and is committed to developing and manufacturing the highest quality products for its customers and patients, while maintaining a strong clinical research and research and development focus to quickly respond to customer needs and advance therapeutic modalities.
The new building will house more than 800 employees on the 5.13-acre site.